As small biotech companies go, Orthocell is killing it with 2-6% fluctuations
Im just pissed off with management for not pushing harder for approvals, partnerships, communication is still rubbish. With very little interest from investors, turning over a few hundred thousand shares day in day out is never going to change the share price. I need to see a US partner who is keen to take products commercially, not just talk about it the last five years
We know the share price will jump up to 30% on a good announcement, but I want it to grow from there 50, 60, 80% eventually ticking over 100% and holding, waiting for the next increase
Ann: Appendix 4C - Quarterly, page-23
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.030(8.11%) |
Mkt cap ! $83.73M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.5¢ | 38.5¢ | $284.0K | 720.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22248 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 208719 | 7 |
View Market Depth
| Last trade - 15.58pm 11/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |